Home Ingredients Tocotrienols (Vitamin E Family)
AntioxidantCardiovascularCognitive

Tocotrienols (Vitamin E Family)

Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Tocotrienols are the less common 4 of 8 vitamin E family members — distinct from the 4 tocopherols. Found primarily in palm oil, annatto, rice bran. Have unique double bonds in side chain that confer different biological activity than tocopherols — particularly membrane antioxidant activity in laboratory assays, effects on the lipid profile (mainly raising HDL), and preclinical neuroprotection and anti-cancer research. Annatto-derived delta + gamma tocotrienols are popular branded forms (DeltaGold®, EVNol SupraBio™).

Studied Dose 100-400 mg/day total tocotrienols; cholesterol/CV 200-300 mg gamma+delta; bone health 100-200 mg/day.
Active Compound Alpha-, Beta-, Gamma-, Delta-Tocotrienols (4 isomers; gamma + delta most studied)

Benefits

Cholesterol-Lowering Effects

Gamma- and delta-tocotrienols inhibit HMG-CoA reductase (the same enzyme statins target), and early trials suggested modest LDL reductions. However, a 2020 meta-analysis of randomized trials did NOT confirm any significant reduction in LDL, total cholesterol, or triglycerides overall; the clearest lipid effect was a modest increase in HDL ("good") cholesterol, with a triglyceride decrease only at higher doses (≥200 mg/day).

Supported by Trial 2

Antioxidant Activity (Distinct from Tocopherols)

Tocotrienols have a unique unsaturated isoprenoid side chain and distribute more readily into cell membranes than tocopherols. Laboratory (in-vitro) assays suggest they can have stronger membrane antioxidant activity than alpha-tocopherol, though this has not been shown to translate into a clinical antioxidant advantage.

Supported by Trial 2, Trial 1

Neuroprotection (Stroke Research)

Nanomolar concentrations of alpha-tocotrienol protect neurons from glutamate-induced excitotoxicity (stroke model) in preclinical research. Clinical translation is still pending, so neuroprotective applications remain theoretical.

Supported by Trial 1, Trial 2

Bone Health (Animal Evidence)

Animal studies show tocotrienols may modestly support bone mineral density and reduce bone resorption markers. Human evidence is limited; some trials in postmenopausal women show modest benefit.

Supported by Trial 2

Non-Alcoholic Fatty Liver Disease (NAFLD)

Trials show tocotrienols modestly reduce hepatic steatosis, ALT, and AST in NAFLD patients. The effect is modest; lifestyle intervention remains foundational.

Supported by Trial 1

Mechanism of action

1

HMG-CoA Reductase Inhibition

Tocotrienols (especially gamma- and delta-) suppress HMG-CoA reductase via post-transcriptional regulation — reducing cholesterol synthesis. Mechanism distinct from but partially overlapping with statins. Note: although this mechanism can reduce cholesterol synthesis in cell and animal models, a pooled meta-analysis of human trials did not confirm a significant LDL- or total-cholesterol-lowering effect.

2

Membrane Distribution

Unsaturated isoprenoid side chain allows tocotrienols to penetrate cell membranes more uniformly than tocopherols. May concentrate at membrane sites where lipid peroxidation occurs — explains potent antioxidant effects in some assays.

3

Anti-Inflammatory NF-κB Inhibition

Tocotrienols (especially gamma and delta) inhibit NF-κB signaling — reducing inflammatory cytokine production. Basis for anti-inflammatory and anti-cancer research.

4

Tocopherol Antagonism (Important Caution)

Alpha-tocopherol (the most common vitamin E form in supplements) interferes with tocotrienol absorption and biological activity. Tocotrienol products are typically alpha-tocopherol-free or low. Concurrent high-dose alpha-tocopherol supplementation NEGATES tocotrienol benefits.

Clinical trials

1
Tocotrienols for NAFLD

Clinical trial of mixed tocotrienols (200 mg BID) vs placebo in 87 NAFLD patients for 12 months. Outcomes: hepatic steatosis (ultrasound), liver enzymes, lipid panel.

87 NAFLD patients.

Tocotrienols significantly improved hepatic steatosis grade, reduced AST and ALT vs placebo. Lifestyle intervention remains foundational for NAFLD; tocotrienols adjunctive.

2
Tocotrienols for Cholesterol — Multiple Clinical Trial

Multiple clinical trials of tocotrienols (typically 100-200 mg/day) for hypercholesterolemia. Effect varies with formulation, baseline cholesterol, and concurrent alpha-tocopherol intake.

Hypercholesterolemic adults.

Early trials suggested modest LDL reductions with annatto-derived gamma+delta tocotrienols, but a 2020 pooled meta-analysis did not confirm a significant LDL, total-cholesterol, or triglyceride reduction; the consistent effect was a modest HDL increase. Effect on lipids is attenuated by concurrent alpha-tocopherol.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
GI distress at high doses.
Bleeding risk at very high doses (vitamin E family inhibits platelet function).
Headache rare.
Fatigue rare.

Important Drug interactions

Anticoagulants (warfarin, apixaban, rivaroxaban) — vitamin E family inhibits platelet aggregation; theoretical bleeding risk; monitor.
Antiplatelet drugs (aspirin, clopidogrel) — additive bleeding risk.
Statins — theoretical additive cholesterol effect; mechanism partially overlapping (HMG-CoA reductase); generally compatible.
Cyclosporine — vitamin E may modestly increase levels.
Alpha-tocopherol supplementation — interferes with tocotrienol benefits; avoid concurrent high-dose mixed tocopherol supplements.
Cholesterol-lowering bile acid sequestrants — may reduce tocotrienol absorption.

More Antioxidant Ingredients

Antioxidant
Green Tea
Green tea extract, derived from Camellia sinensis leaves, is rich in antioxidants like cat…
Antioxidant
NAC (N-Acetylcysteine)
NAC (N-Acetyl Cysteine) is a supplemental form of the amino acid cysteine, best known for…
Antioxidant
Lutein
Lutein is a yellow carotenoid antioxidant that plays a key role in eye health, particularl…
Antioxidant
Vitamin E
Vitamin E is a family of fat-soluble antioxidants, the most active being alpha-tocopherol,…

Explore Other Ingredients

Antioxidant
Alpha Lipoic Acid
Alpha-lipoic acid (ALA) is a versatile antioxidant made naturally in the body that is unus…
Antioxidant
Setria® Glutathione
Setria® is Kyowa Hakko's patented reduced L-glutathione (GSH) produced via fermentation —…
Antioxidant
Milk Thistle
Milk thistle, from the Silybum marianum plant, contains silymarin, a group of plant compou…

Frequently asked questions about Tocotrienols (Vitamin E Family)

What are tocotrienols?

Tocotrienols are a less common subgroup of the vitamin E family (distinct from the more familiar tocopherols), found in palm, rice bran, and annatto. They are studied for cholesterol, liver, and cardiovascular support and for potent antioxidant activity.

How are tocotrienols different from tocopherols?

Both are forms of vitamin E, but tocotrienols have a slightly different structure that may give them stronger antioxidant action in cell membranes and some unique effects on cholesterol and the liver. Many tocotrienol products are tocopherol-free to avoid interference.

How much tocotrienols should I take?

Studies commonly use about 100 to 300 mg of tocotrienols per day, often from annatto or rice bran. Take them with food (with fat) for absorption, and split larger doses. Give cholesterol or other goals several weeks.

Are tocotrienols safe?

They are generally well tolerated. Like other vitamin E forms, they may have a mild blood-thinning effect at higher doses, so check with your doctor if you take anticoagulants or are having surgery.

What is Tocotrienols?

Tocotrienols are the less common 4 of 8 vitamin E family members — distinct from the 4 tocopherols. Found primarily in palm oil, annatto, rice bran. Have unique double bonds in side chain that confer different biological activity than tocopherols — particularly membrane antioxidant activity in laboratory assays, effect…

What is Tocotrienols used for?

Tocotrienols is researched primarily for Antioxidant, Cardiovascular, and Cognitive. Gamma- and delta-tocotrienols inhibit HMG-CoA reductase (the same enzyme statins target), and early trials suggested modest LDL reductions.

What is the recommended dosage of Tocotrienols?

The clinically studied dose is 100-400 mg/day total tocotrienols; cholesterol/CV 200-300 mg gamma+delta; bone health 100-200 mg/day. Always follow the product label and check with a healthcare provider for personal advice.

Is Tocotrienols safe, and does it have side effects?

For most healthy adults, Tocotrienols is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. GI distress at high doses. It may also interact with some medications. Tocotrienols is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Tocotrienols interact with any medications?

Possible interactions include: Anticoagulants (warfarin, apixaban, rivaroxaban) — vitamin E family inhibits platelet aggregation; theoretical bleeding risk; monitor. Antiplatelet drugs (aspirin, clopidogrel) — additive bleeding risk. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Tocotrienols?

NutraSmarts rates the evidence for Tocotrienols as Limited (2 out of 5). It is backed by 2 clinical trials and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Zuo S, Wang G, Han Q, et al. The effects of tocotrienol supplementation on lipid profile: A meta-analysis of randomized controlled trials. Complement Ther Med. 2020;52:102450..PubMedUsed to support: Meta-analysis (15 RCTs) finding tocotrienols did NOT significantly reduce LDL, total cholesterol, or triglycerides overall; the only significant lipid effect was an increase in HDL-C (with a triglyceride decrease at doses ≥200 mg/day).